Cardiac Markers Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019
Summary
The Publisher's Medical Devices sector report, “Cardiac Markers Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019" provides an overview of Cardiac Markers Rapid Tests & Point of Care (POC) currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Markers Rapid Tests & Point of Care (POC) pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by the Publisher's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Reasons to Buy
The report enables you to:
Summary
The Publisher's Medical Devices sector report, “Cardiac Markers Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019" provides an overview of Cardiac Markers Rapid Tests & Point of Care (POC) currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Markers Rapid Tests & Point of Care (POC) pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by the Publisher's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Cardiac Markers Rapid Tests & Point of Care (POC) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Cardiac Markers Rapid Tests & Point of Care (POC) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Cardiac Markers Rapid Tests & Point of Care (POC) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
1.1 List of Tables1.2 List of Figures
2 Introduction
2.1 Cardiac Markers Rapid Tests & Point of Care (POC) Overview
3 Products under Development
3.1 Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development
3.2 Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Segment
3.3 Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Territory
3.4 Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Regulatory Path
3.5 Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Estimated Approval Date
4 Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products under Development by Companies
4.1 Cardiac Markers Rapid Tests & Point of Care (POC) Companies - Pipeline Products by Stage of Development
4.2 Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development
5 Cardiac Markers Rapid Tests & Point of Care (POC) Companies and Product Overview
5.1 1Drop Diagnostics Company Overview
5.1.1 1Drop Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
5.2 Abbott Point of Care Inc Company Overview
5.2.1 Abbott Point of Care Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Accel Diagnostics LLC Company Overview
5.3.1 Accel Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.4 Akers Biosciences Inc Company Overview
5.4.1 Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 Akrivis Technologies LLC Company Overview
5.5.1 Akrivis Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.6 Alfa Wassermann Inc Company Overview
5.6.1 Alfa Wassermann Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Angle Biosciences Inc Company Overview
5.7.1 Angle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Anteo Diagnostics Ltd Company Overview
5.8.1 Anteo Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.9 Atonomics A/S Company Overview
5.9.1 Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview
5.10 Axis-Shield Diagnostics Ltd Company Overview
5.10.1 Axis-Shield Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.11 BBB Technologies Inc Company Overview
5.11.1 BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Bio-AMD Inc Company Overview
5.12.1 Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview
5.13 BioMedomics Inc Company Overview
5.13.1 BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 BiOracle Ltd (Inactive) Company Overview
5.14.1 BiOracle Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.15 Biosensia Ltd Company Overview
5.15.1 Biosensia Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.16 Biostealth, Inc. Company Overview
5.16.1 Biostealth, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.17 Biosurfit, SA Company Overview
5.17.1 Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview
5.18 Brava Diagnostics Company Overview
5.18.1 Brava Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
5.19 Carclo Diagnostic Solutions Ltd Company Overview
5.19.1 Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.20 CardioGenics Inc Company Overview
5.20.1 CardioGenics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.21 Cordex Systems, LLC Company Overview
5.21.1 Cordex Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.22 Coris BioConcept Company Overview
5.22.1 Coris BioConcept Pipeline Products & Ongoing Clinical Trials Overview
5.23 Critical Diagnostics Company Overview
5.23.1 Critical Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
5.24 Diazyme Laboratories Inc Company Overview
5.24.1 Diazyme Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
5.25 DSC Technologies Inc Company Overview
5.25.1 DSC Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.26 Duke University Company Overview
5.26.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview
5.27 Dynasil Corporation of America Company Overview
5.27.1 Dynasil Corporation of America Pipeline Products & Ongoing Clinical Trials Overview
5.28 Edan Instruments Inc Company Overview
5.28.1 Edan Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview
5.29 Epinex Diagnostics Inc Company Overview
5.29.1 Epinex Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.30 ET Healthcare Inc Company Overview
5.30.1 ET Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview
5.31 Group K Diagnostics Company Overview
5.31.1 Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
5.32 LeukoDx Ltd Company Overview
5.32.1 LeukoDx Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.33 MML Ltd Company Overview
5.33.1 MML Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.34 Nanomix Inc Company Overview
5.34.1 Nanomix Inc Pipeline Products & Ongoing Clinical Trials Overview
5.35 Novartis AG Company Overview
5.35.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview
5.36 Ohmx Corp Company Overview
5.36.1 Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview
5.37 OPKO Health Inc Company Overview
5.37.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.38 Prolight Diagnostics AB Company Overview
5.38.1 Prolight Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview
5.39 QLIDA Diagnostics Company Overview
5.39.1 QLIDA Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
5.40 QuickCheck Health Inc Company Overview
5.40.1 QuickCheck Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.41 Quidel Corp Company Overview
5.41.1 Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview
5.42 Radiometer Medical ApS Company Overview
5.42.1 Radiometer Medical ApS Pipeline Products & Ongoing Clinical Trials Overview
5.43 Radisens Diagnostics Ltd Company Overview
5.43.1 Radisens Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.44 Resdin Technologies Inc. Company Overview
5.44.1 Resdin Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.45 Sandia National Laboratories Company Overview
5.45.1 Sandia National Laboratories Pipeline Products & Ongoing Clinical Trials Overview
5.46 Sarissa-Biomedical Ltd Company Overview
5.46.1 Sarissa-Biomedical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.47 Selfa, Inc. Company Overview
5.47.1 Selfa, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.48 SpinChip Diagnostics AS Company Overview
5.48.1 SpinChip Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview
5.49 Thermo Fisher Scientific Inc Company Overview
5.49.1 Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
5.50 ThreeFold Sensors (Inactive) Company Overview
5.50.1 ThreeFold Sensors (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.51 Trinity Biotech Plc Company Overview
5.51.1 Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview
5.52 True Diagnostics Inc Company Overview
5.52.1 True Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.53 Universal Biosensors Inc Company Overview
5.53.1 Universal Biosensors Inc Pipeline Products & Ongoing Clinical Trials Overview
5.54 University of Vermont Company Overview
5.54.1 University of Vermont Pipeline Products & Ongoing Clinical Trials Overview
5.55 Upstream Medical Technologies Ltd Company Overview
5.55.1 Upstream Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.56 XCellCure, LLC Company Overview
5.56.1 XCellCure, LLC Pipeline Products & Ongoing Clinical Trials Overview
6 Cardiac Markers Rapid Tests & Point of Care (POC) - Recent Developments
6.1 Oct 23, 2019: bioMerieux - Third-Quarter 2019 Business Review
6.2 Oct 22, 2019: bioMerieux - Third quarter 2019 business review
6.3 Oct 16, 2019: Trinity Biotech announces results for Q3, 2019
6.4 Sep 04, 2019: bioMerieux announces First-Half 2019 Results
6.5 Aug 20, 2019: Trinity Biotech announces results for Q2, 2019
6.6 May 07, 2019: Trinity Biotech announces results for Q1, 2019
6.7 Apr 24, 2019: bioMerieux: First-quarter 2019 business review
6.8 Mar 07, 2019: Trinity Biotech announces quarter 4 and fiscal year 2018 financial results
6.9 Feb 27, 2019: bioMerieux - 2018 Financial Results
6.10 Jan 25, 2019: Introducing DiaSys’ new CEO Dr. Jan Gorka
6.11 Dec 07, 2018: Quidel comments on California court ruling
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact Us
7.4 Disclaimer
List of Tables
Table 1: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development
Table 2: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Segment
Table 3: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Territory
Table 4: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Regulatory Path
Table 5: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Estimated Approval Date
Table 6: Cardiac Markers Rapid Tests & Point of Care (POC) Companies - Pipeline Products by Stage of Development
Table 7: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development
Table 8: 1Drop Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 9: One Drop Diagnostic Device - Cardiovascular Disease - Product Status
Table 10: One Drop Diagnostic Device - Cardiovascular Disease - Product Description
Table 11: Abbott Point of Care Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: i-STAT TnI-Nx - Product Status
Table 13: i-STAT TnI-Nx - Product Description
Table 14: Accel Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 15: pScreen BNP - Product Status
Table 16: pScreen BNP - Product Description
Table 17: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Diagnostic Test - Heart Attack - Product Status
Table 19: Diagnostic Test - Heart Attack - Product Description
Table 20: Akrivis Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Z-TECT - cTnI Assay - Product Status
Table 22: Z-TECT - cTnI Assay - Product Description
Table 23: Alfa Wassermann Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: ACE Alera Clinical Chemistry System - hsCRP Assay - Product Status
Table 25: ACE Alera Clinical Chemistry System - hsCRP Assay - Product Description
Table 26: ACE Axcel Clinical Chemistry System - hsCRP Assay - Product Status
Table 27: ACE Axcel Clinical Chemistry System - hsCRP Assay - Product Description
Table 28: Angle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 29: Cardiac Troponin Biomarker Kit - Product Status
Table 30: Cardiac Troponin Biomarker Kit - Product Description
Table 31: Anteo Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 32: AtomoRapid - Heart Attack - Product Status
Table 33: AtomoRapid - Heart Attack - Product Description
Table 34: Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Premium Trace - B-type Natriuretic Peptide Assay - Product Status
Table 36: Premium Trace - B-type Natriuretic Peptide Assay - Product Description
Table 37: Trace - D-dimer Test - Product Status
Table 38: Trace - D-dimer Test - Product Description
Table 39: Axis-Shield Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Afinion hsCRP Assay - Product Status
Table 41: Afinion hsCRP Assay - Product Description
Table 42: BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 43: Mobile RDT Reader - Troponin-I Test - Product Status
Table 44: Mobile RDT Reader - Troponin-I Test - Product Description
Table 45: Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 46: Digital Strip Reader - Cardiac Marker Test - Product Status
Table 47: Digital Strip Reader - Cardiac Marker Test - Product Description
Table 48: Magnetic Immunoassay Detection System - Cardiac Myoglobin - Product Status
Table 49: Magnetic Immunoassay Detection System - Cardiac Myoglobin - Product Description
Table 50: Magnetic Immunoassay Detection System - Cardiac Troponin - Product Status
Table 51: Magnetic Immunoassay Detection System - Cardiac Troponin - Product Description
Table 52: Magnetic Immunoassay Detection System - CK MB - Product Status
Table 53: Magnetic Immunoassay Detection System - CK MB - Product Description
Table 54: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 55: Point of Care Test - Troponin - Product Status
Table 56: Point of Care Test - Troponin - Product Description
Table 57: BiOracle Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 58: biO1042 Test - Product Status
Table 59: biO1042 Test - Product Description
Table 60: Biosensia Ltd Pipeline Products & Ongoing Clinical Trials Overview
List of Figures
Figure 1: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development
Figure 2: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Segment
Figure 3: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Territory
Figure 4: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Regulatory Path
Figure 5: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Estimated Approval Date
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 1Drop Diagnostics
- Abbott Point of Care Inc
- Accel Diagnostics LLC
- Akers Biosciences Inc
- Akrivis Technologies LLC
- Alfa Wassermann Inc
- Angle Biosciences Inc
- Anteo Diagnostics Ltd
- Atonomics A/S
- Axis-Shield Diagnostics Ltd
- BBB Technologies Inc
- Bio-AMD Inc
- BioMedomics Inc
- Biosensia Ltd
- Biostealth, Inc.
- Biosurfit, SA
- Brava Diagnostics
- Carclo Diagnostic Solutions Ltd
- CardioGenics Inc
- Cordex Systems, LLC
- Coris BioConcept
- Critical Diagnostics
- Diazyme Laboratories Inc
- DSC Technologies Inc
- Duke University
- Dynasil Corporation of America
- Edan Instruments Inc
- Epinex Diagnostics Inc
- ET Healthcare Inc
- Group K Diagnostics
- LeukoDx Ltd
- MML Ltd
- Nanomix Inc
- Novartis AG
- Ohmx Corp
- OPKO Health Inc
- Prolight Diagnostics AB
- QLIDA Diagnostics
- QuickCheck Health Inc
- Quidel Corp
- Radiometer Medical ApS
- Radisens Diagnostics Ltd
- Resdin Technologies Inc.
- Sandia National Laboratories
- Sarissa-Biomedical Ltd
- Selfa, Inc.
- SpinChip Diagnostics AS
- Thermo Fisher Scientific Inc
- Trinity Biotech Plc
- True Diagnostics Inc
- Universal Biosensors Inc
- University of Vermont
- Upstream Medical Technologies Ltd
- XCellCure, LLC
